Alvogen today announced that it has successfully concluded multiple registration procedures for Lenalidomide capsules.
Highly experienced management team with a proven track record of achieving high growth and profitability.
Download center for company logos and images.
Enter your email to sign up for news alerts
Halldor Kristmannsson Vice PresidentOrganizational DevelopmentGlobal Communications & Branding
Phone (354) 522-2900
EmailConnect on LinkedIn